Report October 2009: Difference between revisions
Jump to navigation
Jump to search
AClearwater (talk | contribs) |
AClearwater (talk | contribs) |
||
| Line 17: | Line 17: | ||
Our knowledge has significantly improved since last month. We have broken down our understnading of IP in kits into: | Our knowledge has significantly improved since last month. We have broken down our understnading of IP in kits into: | ||
#Patents | #Patents | ||
## | ##General Discussion | ||
## Case Law | |||
## Bayh-Dole Act Specific Cases | |||
## Patent Pools | |||
## Patent Clearing Houses | |||
## Legislative Activity | |||
#Licensing | #Licensing | ||
## Licensing Approaches | |||
## Compulsory Licensing | |||
## Licensing Behavior | |||
#Trade Secret | #Trade Secret | ||
## Trade Secret Caselaw | |||
## Limits of protection | |||
## Reverse Engineering | |||
Revision as of 15:40, 20 November 2009
Alternative Energy
Tasks Completed
- Uploaded the AE paper into the wiki
- Added all of the graphs and figures in the the paper
- Edited sections to include new AE findings and to update sections
- Added a new bibliography page and consolidated all sources
- Linked all citations to the new bibliography page and standardized them to conform to Harvard Reference Format.
- Added footnotes into the paper
Biotechnology: Diagnostic Kits
General Status
Status of Scientific and Market Knowledge
- Focusing on Genetic Diagnostics (GDx)
Status of Intellectual Property Knowledge Our knowledge has significantly improved since last month. We have broken down our understnading of IP in kits into:
- Patents
- General Discussion
- Case Law
- Bayh-Dole Act Specific Cases
- Patent Pools
- Patent Clearing Houses
- Legislative Activity
- Licensing
- Licensing Approaches
- Compulsory Licensing
- Licensing Behavior
- Trade Secret
- Trade Secret Caselaw
- Limits of protection
- Reverse Engineering
Bibliography and Paper Organization
- Added and reviewed new articles to the bibliography. Some key reports:
- Secretary's Advisory Committee on Genetics, Health, and Society (SACGHS)âPublic Consultation Draft Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests
- SACGHS Gene Patents Appendix 1
- Cook-Deegan, R., Chandrasekharan, S. & Angrist, M., 2009. The dangers of diagnostic monopolies. Nature, 458(7237), 405-406
- Herder, M., Patents & the Progress of Personalized Medicine: Biomarkers Research as Lens. SSRN eLibrary
- Huys et al. Legal uncertainty in the area of genetic diagnostic testing. Nature Biotech (2009) vol. 27 (10) pp. 903-909
Work Completed
- Initial case studies of commercially available genetic diagnostics
- Bibliography with Literature Review
- Blog Post 1
Work Partially Completed
- IP profile of the biggest for-profit companies in AE
- Overview of Economics of Intellectual Property in Kits
- IP in Kits
- IP Profile of Universities working in Kits
- Commons based cases in Kits
- Interviews with experts on diagnostic kits
- Give an overall picture of the Kits' sector
- Data, narratives and tools produced by the Kits' sector
- Competitive advantages in Kits
Work Remaining
- IP Profile of Biggest for-profit companies in Kits
- IP Profile of non-profit companies in Kits
- IP Profile of Associations in Kits
- Peer-Production Business models in Kits
- Open Business models in Kits
Research Methodology in use
- Case studies
- Literature review
- Government Reports
Problems and Considerations
See Diagnostic_Kits/The_Argument_Framework#Outstanding_Questions